Obesity is a big problem in today’s time due to modern lifestyle and poor diet. Children, old people, elderly people of all ages are struggling with obesity. Wherever you look, whether it is social media, YouTube, TV, news paper, you are full of different types of tips to lose weight or videos are going viral. There is a lot on social media regarding gym, exercise, yoga, diet, fitness goals. Now in the midst of all this, your eyes fall on such a news that ‘just one injection in a week will reduce the weight by 15 kg’, then what will be your reaction? Yes, it is unbelievable but it is true that recently, pharmaceutical giant Eli Lilly has mentioned such a drug to reduce weight, if it comes in the market. Then there will be panic in the world.
Actually, Eli Lilly said, ‘We have recently done a clinical trial of weight loss medicine, the results of which have been very good. The name of this medicine is Tirzepatide. The most important thing about Tirzepatide medicine is that this medicine is used for the treatment of type 2 diabetes under the name ‘Monjaro brand’. Actually, type-2 diabetes patients take this medicine once a week in the form of injection. Now Eli Lilly is demanding that this drug should be launched in the US market in the field of weight loss. So that people can get rid of diseases like obesity. Because nowadays obesity is the root of all diseases. Eli Lilly said that this type 2 diabetes drug was used on obese people for 72 weeks and the result is quite satisfactory.
Results of the medical trial of Tirzepatide drug
According to Eli Lilly, during this entire medical trial, the people who were given an overdose of Tirzepatide medicine. His weight reduced by more than 15 kg in a week. Mild side effects of this medicine were also seen on the patient, such as- gastrointestinal, nausea, vomiting, upset stomach, but the results were quite good. The Indiana-based company said it plans to complete its submission to US authorities in the coming weeks and By the end of the year 2023 this drug can come in the market after fulfilling all its rules.
In a scientific trial published in the year 2021 June, it was kept that the people who were included in this research. He did not have diabetes. Only overweight people were included in this. About 21 percent of the people involved in this research lost weight.
This claim is being made about Tirzepatide medicine
Like other medicines, terzepetide has also become very famous for reducing weight. For your information, let us tell you that terzepetide mimics the gastrointestinal hormone GLP-1. After consuming this medicine, your brain activates the receptors of loss of appetite. However, from May 2022, Monjaro is used in the US for the treatment of diabetes patients. Some doctors already recommend this medicine to people to lose weight. Many experts see GLP-1 analogs as a game-changer, as they cause much greater weight loss than drugs available on the market. It has also been revealed in a research that 40 percent of Americans are suffering from diseases like obesity, this medicine will create panic in the world of medicine. It is being speculated. According to Morgan Stanley, the global market for obesity treatment could be worth $54 billion by 2030.
Read also: You also drink water before drinking tea, so read whether you are doing wrong or right?
